---
title: "Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286271025.md"
description: "Charles River Laboratories and Medipost have signed a memorandum of understanding to collaborate on GMP-compliant testing. The agreement will see Charles River provide services related to biologics quality control, viral testing, and release testing to support Medipost's cell therapy pipeline. Financial terms of the deal were not disclosed."
datetime: "2026-05-13T13:15:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286271025.md)
  - [en](https://longbridge.com/en/news/286271025.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286271025.md)
---

# Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing

09:15 AM EDT, 05/13/2026 (MT Newswires) -- Charles River Laboratories ( CRL ) said Wednesday it and Medipost have signed a memorandum of understanding to collaborate on GMP-compliant testing.

Financial terms weren't disclosed.

Under the MoU, Charles River will offer its services related to biologics quality control, viral testing, release testing, and other GMP-compliant services for the support of Medipost's cell therapy pipeline, the company said.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)